<?xml version="1.0" encoding="UTF-8"?>
<ref id="B23-vaccines-08-00273">
 <label>23.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wolfe</surname>
    <given-names>D.N.</given-names>
   </name>
   <name>
    <surname>Heppner</surname>
    <given-names>D.G.</given-names>
   </name>
   <name>
    <surname>Gardner</surname>
    <given-names>S.N.</given-names>
   </name>
   <name>
    <surname>Jaing</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Dupuy</surname>
    <given-names>L.C.</given-names>
   </name>
   <name>
    <surname>Schmaljohn</surname>
    <given-names>C.S.</given-names>
   </name>
   <name>
    <surname>Carlton</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Current strategic thinking for the development of a trivalent Alphavirus vaccine for human use</article-title>
  <source>Am. J. Trop. Med. Hyg.</source>
  <year>2014</year>
  <volume>91</volume>
  <fpage>442</fpage>
  <lpage>450</lpage>
  <pub-id pub-id-type="doi">10.4269/ajtmh.14-0055</pub-id>
  <?supplied-pmid 24842880?>
  <pub-id pub-id-type="pmid">24842880</pub-id>
 </element-citation>
</ref>
